Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice? Ferro A, Generali D, Caffo O, Caldara A, et al. Semin Oncol 2023 Aug 26:S0093-7754(23)00060.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferro A, Generali D, Caffo O, Caldara A, et al. Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice? Semin Oncol 2023 Aug 26:S0093-7754(23)00060.
PMID: 37673696